Skip to main navigation Skip to search Skip to main content

African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates

  • Yumiko Matsuoka
  • , Amorsolo Suguitan
  • , Marlene Orandle
  • , Myeisha Paskel
  • , Kobporn Boonnak
  • , Donald J. Gardner
  • , Friederike Feldmann
  • , Heinz Feldmann
  • , Michael Marino
  • , Hong Jin
  • , George Kemble
  • , Kanta Subbarao
  • National Institute of Allergy and Infectious Diseases (NIAID)
  • American University of the Caribbean
  • Center for Biologics Evaluation and Research, Food and Drug Administration
  • MedImmune LLC
  • 3-V Biosciences Inc.

Research output: Contribution to journal › Article › peer-review

33 Citations (Scopus)

Abstract

Live attenuated cold-adapted (ca) H5N1, H7N3, H6N1, and H9N2 influenza vaccine viruses replicated in the respiratory tract of mice and ferrets, and 2 doses of vaccines were immunogenic and protected these animals from challenge infection with homologous and heterologous wild-type (wt) viruses of the corresponding subtypes. However, when these vaccine candidates were evaluated in phase I clinical trials, there were inconsistencies between the observations in animal models and in humans. The vaccine viruses did not replicate well and immune responses were variable in humans, even though the study subjects were seronegative with respect to the vaccine viruses before vaccination. Therefore, we sought a model that would better reflect the findings in humans and evaluated African green monkeys (AGMs) as a nonhuman primate model. The distribution of sialic acid (SA) receptors in the respiratory tract of AGMs was similar to that in humans. We evaluated the replication of wt and ca viruses of avian influenza (AI) virus subtypes H5N1, H6N1, H7N3, and H9N2 in the respiratory tract of AGMs. All of the wt viruses replicated efficiently, while replication of the ca vaccine viruses was restricted to the upper respiratory tract. Interestingly, the patterns and sites of virus replication differed among the different subtypes. We also evaluated the immunogenicity and protective efficacy of H5N1, H6N1, H7N3, and H9N2 ca vaccines. Protection from wt virus challenge correlated well with the level of serum neutralizing antibodies. Immune responses were slightly better when vaccine was delivered by both intranasal and intratracheal delivery than when it was delivered intranasally by sprayer. We conclude that live attenuated pandemic influenza virus vaccines replicate similarly in AGMs and human subjects and that AGMs may be a useful model to evaluate the replication of ca vaccine candidates.

Original languageEnglish
Pages (from-to)8139-8152
Number of pages14
JournalJournal of Virology
Volume88
Issue number14
DOIs
Publication statusPublished - Jul 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates'. Together they form a unique fingerprint.

Cite this